Blood Test Could Predict Cancer Risk in Type 2 Diabetes Patients
A blood test measuring IL-6 levels may help identify those with type 2 diabetes who are at high risk of developing obesity-related cancers.
Category: Diabetes & Metabolic Diseases
Diabetes & Metabolic Diseases
Latest
Diabetes & Metabolic Diseases
Latest
Identifying New Methods of Gestational Diabetes Diagnosis
A new study evaluated the diagnostic value of certain markers before or at the time of screening for gestational diabetes mellitus.
Diabetes & Metabolic Diseases
Latest
New Guidelines on Diabetes Testing Aims to Improve Patient CareÂ
ADLM, in collaboration with the ADA, released evidence-based guidelines to help diagnose patients with diabetes using the latest lab tools.Â
Rapid A1c Test Aims to Reduce Diabetes Diagnosis Inaccuracies
Orange Biomed is currently conducting studies of a rapid A1c, a glycated hemoglobin analyzer through single-cell analysis of red blood cells.
Read More
New Test Could Help Identify Type 2 Diabetes Risk
Analyzing changes to DNA in the blood can improve the ability to predict a person’s risk of developing type 2 diabetes within a decade.
Read More
Metabolon Launches Targeted Panels to Help Identify Gut Health Biomarkers
The new panels are designed to target dozens of microbially-derived metabolites across multiple pathways to advance pre-clinical efforts.
Read More
How Gut Microbiota May Help Diagnose Diseases
A recent study compared the gut microbiota and gut-derived metabolites between healthy controls and individuals with fatty liver.
Read More
New Diabetes Diagnostic Method Harnesses Urinary Acetone
A research team has identified a new non-invasive screening method for Type 2 diabetes (T2D) by harnessing urinary acetones.
Read More
Blood-Based Metabolic Signature Outperforms Standard Method for Predicting Diet, Disease Risk
The method uses molecular profiling and AI to develop dietary signatures to predict cardiovascular disease and type 2 diabetes risks.
Read More
New Tech Detects Low Blood Sugar in Older Adults with Diabetes and Alzheimer’s
A scientist is developing health information tech designed to enhance accessibility and value to adults with diabetes and Alzheimer’s disease.
Read More
Journey Biosciences Unveils Solution to Predict Kidney Complications for Diabetes Patients
Journey Biosciences, a company offering predictive risk-screening technologies for diabetes complications, launch its flagship product.
Read More
Screening Adults Aged 40-70 Would Find Undiagnosed Type 2 Diabetes Cases Much Earlier
Using a standard diabetes test to screen all adults in U.K. aged 40-70 years would find undiagnosed cases of type 2 diabetes much earlier.
Read More
Contactless Health Monitoring Device Can Assess Disease Risk
NuraLogix has announced that its contactless health monitoring platform, Anura, will be able to assess metabolic and blood biomarker risks.
Read More
Personalized Kidney Screening for Type 1 Diabetes Patients Could Detect Disease Earlier, Study Finds
A personalized approach to kidney disease screening for type 1 diabetes patients may reduce the time chronic kidney disease goes undetected.
Read More
Three-Protein Signature Used in Detection of Prediabetes
A proteomics approach was used to identify a three-protein signature in the blood that can improve detection of a form of prediabetes.
Read More
Alimentiv, Summit Clinical Research Collaborate to Support Non-Alcoholic Steatohepatitis Clinical Trials
Alimentiv and Summit Clinical Research are collaborating to drive Non-Alcoholic Steatohepatitis drug development programs forward.
Read More
COVID Associated with Up to 72% Increase in Type 1 Diabetes Diagnosis for Children
Children who were infected with COVID show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study.
Read More
Cold Method for Clearer Fatty Liver Observation Found
Nonalcoholic steatohepatitis, a type of fatty liver disease that might progress to cancer, is a prevalent health concern among the obese.
Read More